Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co ( (HK:1349) ) has issued an announcement.
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co has entered into an agreement with SPD Bank to subscribe to a structured deposit product worth RMB210 million. This investment utilizes the company’s idle funds from daily operations, and the transaction is categorized as a disclosable transaction under the Listing Rules due to the applicable percentage ratios exceeding 5% but remaining below 25%. The structured deposit is principal-guaranteed with a floating return, linked to the EUR/USD exchange rate, and assessed as low-risk by SPD Bank. The agreement does not allow for early termination by the company, although SPD Bank retains this right under certain conditions.
More about Shanghai Fudan Zhangjiang Bio Pharmaceutical Co
Average Trading Volume: 18,682,939
Current Market Cap: HK$1.15B
See more data about 1349 stock on TipRanks’ Stock Analysis page.